Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01128413 · ClinicalTrials.gov registry record · NA

Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT)

A NA study, sponsored by Washington University School of Medicine.

Terminated
Registry status
NA
Development phase
22
Enrollment target

NCT01128413 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 22 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01128413, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.

TERMINATED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

The short term goal of this study is to evaluate a non-invasive approach that optimizes intravenous (IV) fluid administration according to heart performance and results in surrogate improvements in morbidity and mortality via lactate clearance. Additional objectives include comparative assessments of methods for determining volume responsiveness and establishing a prevalence of volume responsive shock in the Emergency Department (ED).

Interventions

  • DEVICE Cheetah NICOM® PLRT
  • DEVICE USCOM ® (Ultrasound Cardiac Output Monitor)
  • DEVICE Inferior Vena Cava (IVC) Ultrasound Collapsibility
  • BEHAVIORAL CURVES Questionnaire
  • BIOLOGICAL Lactate Clearance

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2010-07
Est. Completion 2013-11
Phase NA

What the Registry Record Tells You About NCT01128413

The ClinicalTrials.gov registry entry for NCT01128413 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Cheetah NICOM® PLRT is the first listed.

NCT01128413 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01128413 about?

NCT01128413 is a clinical study titled "Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT)". The short term goal of this study is to evaluate a non-invasive approach that optimizes intravenous (IV) fluid administration according to heart performance and results in surrogate improvements in morbidity and mortality via lactate clearance. Additional objectives include comparative assessments o...

What is the current status of trial NCT01128413?

This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2010-07. Estimated completion is 2013-11.

What interventions are being tested in trial NCT01128413?

The interventions under investigation include: Cheetah NICOM® PLRT (DEVICE), USCOM ® (Ultrasound Cardiac Output Monitor) (DEVICE), Inferior Vena Cava (IVC) Ultrasound Collapsibility (DEVICE), CURVES Questionnaire (BEHAVIORAL), Lactate Clearance (BIOLOGICAL).

Who is sponsoring clinical trial NCT01128413?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.